Literature DB >> 19458521

Epigenetics and assisted reproduction.

Louise Wilkins-Haug1.   

Abstract

PURPOSE OF REVIEW: Epigenetics encompasses multiple mechanisms by which DNA transcription is altered in various tissues and at different times without changing the underlying gene sequence. Epigenetics plays a key role, especially during embryo and trophoblast development. As assisted reproduction technologies (ARTs) are used during these periods, a potential window of vulnerability exists during which epigenetic alterations may occur. RECENT
FINDINGS: Evidence for epigenetic alterations following ARTs was established based on an increased incidence of imprinting disorders, a particular epimutation in gametes. Recent work suggests induced ovulation and oocytes with potentially less stable imprints may contribute to a higher rate of the maternal imprint disorders noted. Alternatively, new findings of imprinting abnormalities in oligospermatic men again raise the question as to whether subfertility itself is associated with epimutations.
SUMMARY: Currently, our understanding of epigenetics and assisted reproduction is incomplete. Further searches for ART infants with imprinting diseases are hampered by their rare nature. Perhaps more importantly attention has turned to understanding imprinting and epigenetics in placental function. Further analysis of placental epimutations may provide insight into the higher rates of adverse outcomes such as growth restriction that follow ARTs.

Entities:  

Mesh:

Year:  2009        PMID: 19458521     DOI: 10.1097/GCO.0b013e32832d7b95

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  9 in total

Review 1.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

2.  Epigenetics and microRNAs in preeclampsia.

Authors:  Mahua Choudhury; Jacob E Friedman
Journal:  Clin Exp Hypertens       Date:  2012-04-02       Impact factor: 1.749

Review 3.  DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.

Authors:  Jörg Tost
Journal:  Mol Biotechnol       Date:  2010-01       Impact factor: 2.695

4.  Epigenetics and fetal adaptation to perinatal events: diversity through fidelity.

Authors:  L A Joss-Moore; D B Metcalfe; K H Albertine; R A McKnight; R H Lane
Journal:  J Anim Sci       Date:  2009-10-23       Impact factor: 3.159

5.  Placental development during early pregnancy in sheep: effects of embryo origin on fetal and placental growth and global methylation.

Authors:  Anna T Grazul-Bilska; Mary Lynn Johnson; Pawel P Borowicz; Loren Baranko; Dale A Redmer; Lawrence P Reynolds
Journal:  Theriogenology       Date:  2012-10-30       Impact factor: 2.740

Review 6.  MicroRNAs as Potential Serum Biomarkers for Early Detection of Ectopic Pregnancy.

Authors:  Emmanuel N Kontomanolis; Sofia Kalagasidou; Zacharias Fasoulakis
Journal:  Cureus       Date:  2018-03-19

7.  The Impact of Down-Regulation on Obstetrics and Perinatal Outcomes in Singleton Pregnancies After In Vitro Fertilization.

Authors:  Lei Jin; Jihui Ai; Yu Zheng; Biao Chen; Lan Wang; Xiyuan Dong
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555

8.  The Lin28/Let-7 system in early human embryonic tissue and ectopic pregnancy.

Authors:  Teresa Lozoya; Francisco Domínguez; Antonio Romero-Ruiz; Liliana Steffani; Sebastián Martínez; Mercedes Monterde; Blanca Ferri; Maria Jose Núñez; Omar Zamora; Marta Gurrea; Susana Sangiao-Alvarellos; Olivia Vega; Carlos Simón; Antonio Pellicer; Manuel Tena-Sempere
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Embryonic miRNA profiles of normal and ectopic pregnancies.

Authors:  Francisco Dominguez; Juan Manuel Moreno-Moya; Teresa Lozoya; Ainhoa Romero; Sebastian Martínez; Mercedes Monterde; Marta Gurrea; Blanca Ferri; Maria Jose Núñez; Carlos Simón; Antonio Pellicer
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.